Teva Pharmaceutical Industries Ltd. — Capital/Financing Update 2006

Jan 29, 2006

C002	��� ������ ��������� ��"�		2
Public	TEVA- PHARMACEUTICAL INDUSTRIES LTD.
	2529	Corporation no: 520013954
	Stock Exchange/Market: ���
	310
	380	P.O.B 3190 , Petach Tikva 49131 , ,
	Tel: 03-9267297 , 03-9267281 Fax: 03-9267429
	E.mail address: Liraz.Kalif@Teva.co.il	Date of transmission: 29/01/2006
		Time of broadcast: 09:53 09:53:17
		Reference: 2006-02-017073

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on TEVA ANNOUNCES PRICING OF $1.25 BILLION OF CONVERTIBLE DEBENTURES
ConvertiblesPricingFinal270106_isa.pdf

Please find attached a press release and its non-binding hebrew translation, provided for convenience purposes only
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 28/12/2005
- - -
Name of the Signatory : Suesskind Dan , , Position of Signatory in the reporting corporation: Chief Financial Officer
Basel Telephone: 02-5892840 , Facsimile: 02-5892839 , E-mail: dan.suesskind@teva.co.il